about
Resveratrol-decreased hyperalgesia mediated by the P2X7 receptor in gp120-treated ratsThe impact of antiretroviral therapy on symptom burden among HIV outpatients with low CD4 count in rural Uganda: nested longitudinal cohort studyThe Protective Effects of IGF-1 on Different Subpopulations of DRG Neurons with Neurotoxicity Induced by gp120 and Dideoxycytidine In Vitro.Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy.Self-Injurious Behavior Secondary to Cytomegalovirus-Induced Neuropathy in an SIV-Infected Rhesus Macaque (Macaca mulatta)Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy.Antinociceptive effects of topical mepivacaine in a rat model of HIV-associated peripheral neuropathic pain.Voltage-gated calcium channels and their auxiliary subunits: physiology and pathophysiology and pharmacologyA comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients.A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders.HIV positive patient with GBS-like syndrome.Altered expression of the voltage-gated calcium channel subunit α₂δ-1: a comparison between two experimental models of epilepsy and a sensory nerve ligation model of neuropathic pain.P2Y12 receptor upregulation in satellite glial cells is involved in neuropathic pain induced by HIV glycoprotein 120 and 2',3'-dideoxycytidine.Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.Racial and socioeconomic disparities in the symptom reporting of persons living with HIV.
P2860
Q33752131-4150B20C-1879-44A9-A5A9-218F8F27F42CQ33901259-F58C3ACE-FF45-4F55-91DE-F3169F6635A5Q34632883-F987A159-5A0D-4253-9587-335B779BDE36Q35689152-DF050162-EAF1-4C27-BA3A-54B7BE4B2864Q35798495-6CDA44AD-0474-47BC-BA00-9D075C9A83BCQ36177503-D156108E-D26E-4C8C-B84A-4C5026B0B09DQ36992589-41F1B7DD-30F8-4B9E-96C1-F50E49739A3EQ37298134-9BA65850-04FB-4D26-9F41-1161187C268CQ37530893-403080B6-DFB9-46CF-A881-B267497F283BQ38874455-5B200E8D-716E-4DEF-B460-E8ABD73CEBB7Q42363071-329C4FEC-E610-4782-B4BC-AB05B59A640DQ42535767-FD8CE88F-F1A5-43B2-87C0-E20D6EA5CEFCQ47380119-D8D1F167-A25C-435E-B42F-FDFD309F5AF9Q47630662-4C348ECF-17E4-4C77-A0FC-E802CEBA26A5Q47642992-93055C62-FF98-4953-B633-56CD3E8BCB1F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV-related neuropathy: current perspectives.
@en
HIV-related neuropathy: current perspectives.
@nl
type
label
HIV-related neuropathy: current perspectives.
@en
HIV-related neuropathy: current perspectives.
@nl
prefLabel
HIV-related neuropathy: current perspectives.
@en
HIV-related neuropathy: current perspectives.
@nl
P2860
P356
P1476
HIV-related neuropathy: current perspectives.
@en
P2093
Jessica Robinson-Papp
Sonja G Schütz
P2860
P304
P356
10.2147/HIV.S36674
P407
P577
2013-09-11T00:00:00Z